Shannon Thyme Klinger
CIK: 0001866132
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Moderna, Inc.
Discretionary Trading P&L
Holdings
Transaction History (84 total)
- Sep 4, 2026MRNA
Moderna, Inc.
Exercise(M)Direct11.8K shares- - Sep 4, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct5.7K shares at avg. $148.87$849K - Sep 1, 2026MRNA
Moderna, Inc.
Sale(S)Direct3.5K shares at avg. $139.95$486K - Sep 1, 2026MRNA
Moderna, Inc.
Exercise(M)Direct3.5K shares at avg. $30.96$107K - Sep 1, 2026MRNA
Moderna, Inc.
Exercise(M)Direct2.2K shares- - Sep 1, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct1K shares at avg. $140.34$147K - Aug 28, 2026MRNA
Moderna, Inc.
Exercise(M)Direct329 shares- - Aug 28, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct160 shares at avg. $142.77$23K - Aug 27, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct375 shares at avg. $149.66$56K - Aug 27, 2026MRNA
Moderna, Inc.
Exercise(M)Direct774 shares- - Jun 5, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct5.7K shares at avg. $51.59$294K - Jun 5, 2026MRNA
Moderna, Inc.
Exercise(M)Direct11.8K shares- - Jun 4, 2026MRNA
Moderna, Inc.
Exercise(M)Direct3.5K shares at avg. $30.96$107K - Jun 4, 2026MRNA
Moderna, Inc.
Sale(S)Direct3.5K shares at avg. $50.00$174K - Jun 1, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct1K shares at avg. $47.19$49K - Jun 1, 2026MRNA
Moderna, Inc.
Exercise(M)Direct2.2K shares- - May 28, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct159 shares at avg. $47.61$8K - May 28, 2026MRNA
Moderna, Inc.
Exercise(M)Direct328 shares- - May 27, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct374 shares at avg. $47.03$18K - May 27, 2026MRNA
Moderna, Inc.
Exercise(M)Direct773 shares- - Mar 5, 2026MRNA
Moderna, Inc.
Tax Payment(F)Direct5.7K shares at avg. $57.80$330K - Mar 5, 2026MRNA
Moderna, Inc.
Exercise(M)Direct11.8K shares- - Mar 2, 2026MRNA
Moderna, Inc.
Exercise(M)Direct13.9K shares at avg. $30.96$430K - Mar 2, 2026MRNA
Moderna, Inc.
Sale(S)Direct13.9K shares at avg. $52.29$726K - Mar 1, 2026MRNA
Moderna, Inc.
Award(A)DirectStock Option (Right to Buy)
29.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | MRNA Moderna, Inc. | Exercise(M) | 11,797 | - | $0 | Direct |
| Sep 4, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 5,704 | $148.87 | $849,154 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Sale(S) | 3,471 | $139.95 | $485,766 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Exercise(M) | 3,471 | $30.96 | $107,462 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Exercise(M) | 2,166 | - | $0 | Direct |
| Sep 1, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 1,048 | $140.34 | $147,076 | Direct |
| Aug 28, 2026 | MRNA Moderna, Inc. | Exercise(M) | 329 | - | $0 | Direct |
| Aug 28, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 160 | $142.77 | $22,843 | Direct |
| Aug 27, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 375 | $149.66 | $56,123 | Direct |
| Aug 27, 2026 | MRNA Moderna, Inc. | Exercise(M) | 774 | - | $0 | Direct |
| Jun 5, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 5,705 | $51.59 | $294,321 | Direct |
| Jun 5, 2026 | MRNA Moderna, Inc. | Exercise(M) | 11,798 | - | $0 | Direct |
| Jun 4, 2026 | MRNA Moderna, Inc. | Exercise(M) | 3,471 | $30.96 | $107,462 | Direct |
| Jun 4, 2026 | MRNA Moderna, Inc. | Sale(S) | 3,471 | $50.00 | $173,550 | Direct |
| Jun 1, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 1,047 | $47.19 | $49,408 | Direct |
| Jun 1, 2026 | MRNA Moderna, Inc. | Exercise(M) | 2,165 | - | $0 | Direct |
| May 28, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 159 | $47.61 | $7,570 | Direct |
| May 28, 2026 | MRNA Moderna, Inc. | Exercise(M) | 328 | - | $0 | Direct |
| May 27, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 374 | $47.03 | $17,589 | Direct |
| May 27, 2026 | MRNA Moderna, Inc. | Exercise(M) | 773 | - | $0 | Direct |
| Mar 5, 2026 | MRNA Moderna, Inc. | Tax Payment(F) | 5,704 | $57.80 | $329,691 | Direct |
| Mar 5, 2026 | MRNA Moderna, Inc. | Exercise(M) | 11,797 | - | $0 | Direct |
| Mar 2, 2026 | MRNA Moderna, Inc. | Exercise(M) | 13,885 | $30.96 | $429,880 | Direct |
| Mar 2, 2026 | MRNA Moderna, Inc. | Sale(S) | 13,885 | $52.29 | $726,047 | Direct |
| Mar 1, 2026 | MRNA Moderna, Inc. | Award(A) Stock Option (Right to Buy) | 29,275 | - | - | Direct |
1-25 of 84 transactions
About Klinger Shannon Thyme
Klinger Shannon Thyme (SEC CIK 0001866132) files insider reports with the SEC as Chief Legal Officer of Moderna, Inc. (MRNA).
Signal8 holds 27 ownership filings by Klinger Shannon Thyme, all Form 4s, filed between Sep 4, 2024 and Sep 8, 2026. Those filings report 84 transactions, from Aug 30, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Klinger Shannon Thyme's filings is in CAMBRIDGE, MA.
Recent filings by Klinger Shannon Thyme
- Sep 4, 2026: Option exercise of MRNA shares (Form 4, code M).
- Sep 4, 2026: Tax withholding of MRNA shares (Form 4, code F).
- Sep 1, 2026: Open-market sale of MRNA shares (Form 4, code S).
- Sep 1, 2026: Option exercises of MRNA shares (2 lines, Form 4, code M).
- Sep 1, 2026: Tax withholding of MRNA shares (Form 4, code F).
Other insiders filing for Moderna, Inc. (MRNA)
- Hoge Stephen, President
- Mock James M, Chief Financial Officer
- Andres Juan, Chief Operating Officer
- Bancel Stephane, Chief Executive Officer
- McDonnell Michael R., Director
- Banque Soria Ester, Chief Commercial Officer